- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04644172
Improving Thinking in Everyday Life After Covid-19
Improving Thinking in Everyday Life: Pilot Study C
Study Overview
Status
Conditions
Detailed Description
The purpose of this pilot study is to develop and test an intervention for slow processing of sensory input that not only increases the speed of processing but also produces improvement in how much and how well adults with this type of cognitive impairment carry out everyday tasks that rely on cognitive function. The intervention will combine Speed of Processing Training (SOPT) with a modified form of the Transfer Package (TP) from Constraint-Induced Movement therapy (CI therapy). SOPT has been shown to increase speed of processing in a variety of patient populations. The Transfer Package has been shown to produce transfer of gains from the treatment setting to everyday life when combined with training of arm use in the treatment in adults after stroke.
This early phase, randomized controlled trial (RCT) will have two arms: Immediate SOPT+TP (experimental group) and Delayed SOPT+TP (control group). The Immediate SOPT+TP group will receive the experimental intervention immediately after pre-treatment testing, and then be followed for a year. The Delayed SOPT+TP group will receive testing on the same schedule as the Immediate group up to 3-month follow-up. Delayed group participants will be permitted to receive care that is available in the community as part of typical clinical care during this period. After 3-month follow-up testing, Delayed group participants will receive the experimental intervention and then be followed up for a year. Thus, the study design is a RCT with a usual care control group featuring crossover to the experimental intervention for that group at 3 month follow-up.
In the experimental intervention, the length of each treatment session will vary from 2 to 3.5 hours per day, the number of treatment days per week will range from 2 to 5, and the number of weeks of treatment will range from 2 to 10. Accordingly, the interval between testing occasions may change depending on the findings from initial pilot work. Total hours of treatment will not exceed 35. Ranges are given rather than precise values because part of the purpose of this pilot work is to decide, on a preliminary basis, what is the best schedule of delivery. In addition, four follow-up telephone calls will be conducted each week for the first month after the end of treatment. Then, a follow-up telephone call will be placed once a month for up to 11 months. These telephone calls will permit elements of the Transfer Package to be delivered remotely, helping the patient to transition from taking part in treatment to living their daily lives. Each telephone call will last 30 to 60 minutes.
If a caregiver is available, the caregiver will be asked to complete interviews about the participant's progress (see below) and will be invited to support the participant in following the Transfer Package elements of the treatment (see below).
The outcomes that will be assessed are: speed of processing, performance of instrumental activities of daily living (IADL) that place demands on cognitive activity in the laboratory setting, and performance of IADL that place demands on cognitive activity outside the laboratory setting.
The diagram immediately below shows the treatment and testing schedule for the Immediate Treatment group.
Informed Consent Interview → Screening → Pre-treatment Testing → Treatment (2-10 weeks) → Post-treatment testing → up to 4 weekly follow-up phone calls → up to 2 monthly follow-up phone calls → 3-month follow-up testing → up to 9 monthly follow-up calls → 12-month follow-up testing
The diagram immediately below show the treatment and testing schedule for the Delayed Treatment group.
Informed Consent Interview → Screening → Baseline Testing 1 → Usual care (2-10 weeks) → Baseline Testing 2 → 3 months → Pre-treatment Testing → Treatment (2-10 weeks) → Post-treatment testing → up to 4 weekly follow-up phone calls → up to 2 monthly follow-up phone calls → 3-month follow-up testing → up to 9 monthly follow-up calls → 12-month follow-up testing
Repeated measures analysis of variance models with a between-subjects factor will be used to evaluate if statistically significant improvements take place as a result of treatment. The primary comparison will be between the Immediate Treatment and Delayed Treatment groups at post-treatment. The cross-over design permits a another, secondary evaluation of the efficacy of the experimental intervention by comparing the usual care to the SOPT+TP period in the Delayed Treatment group.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Staci McKay
- Phone Number: 205-934-9768
- Email: stacemc@uab.edu
Study Contact Backup
- Name: Edward Taub, Ph.D.
- Phone Number: 205-934-2471
- Email: etaub@uab.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- Recruiting
- University of Alabama at Birmingham
-
Contact:
- Staci McKay
-
Contact:
- Edward Taub
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- presence of cognitive impairment due to Covid-19 infection
- mild-to-moderate general cognitive impairment as determined by a Montreal Cognitive Assessment (MOCA) score between 10-25
- at least 3 months after positive status for Covid-19
- 18 years or older
- medically stable
- sufficiently fit, from both a physical and mental health perspective, to take part in study
- adequate sight and hearing to complete UFOV test
- adequate thinking skills, e.g., ability to follow directions, retain information, to complete UFOV and CTAL, as marked by judgement of the screener that the candidate is able to adequately complete the UFOV and CTAL
- reside in the community (as opposed to a hospital or skilled nursing facility)
- able to travel to laboratory on multiple occasions
- caregiver available
Exclusion Criteria:
- cognitive impairment due to a developmental disability, psychiatric disorder, or substance abuse
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Immediate Treatment
The treatment will have 3 components.
The first component, Speed of Processing Training, is a computer game.
Participants identify targets on the screen as rapidly as possible.
The second component is training following shaping principles on simulated instrumental activities of daily living (IADL), such as making a telephone call or generating a shopping list, in the treatment setting.
Shaping involves progressively increasingly the complexity of a task in incremental steps as a participant gains mastery.
Frequent, positive feedback is another important aspect of shaping.
The third component is a set of psychological techniques that will help participants apply the improvements from the game to carrying out tasks that rely on thinking in their daily
|
Behavioral Contract.
At the outset of treatment, the therapist negotiates a contract with the participant and caregiver, if one is available.Daily home diary.
During treatment, the participants catalog the ADL and IADL for the part of the day spent outside the laboratory.
Daily administration of the Cognitive Task Activity Log (CTAL).
The CTAL collects information about attempts by the participant to complete ADL and IADL.
Problem Solving.
The therapist helps participants to think through any barriers to completing ADL and IADL independently.
Home skill assignments during treatment.
Participants are assigned on a written check-off sheet 10 specific ADL tasks.
Home skill assignments after treatment.
Toward the end of treatment, a written individualized post-treatment program is developed containing a list of up to 10 IADL for each day of the week.
Post-treatment telephone contacts.
Participants are contacted during the 12 month period after treatment to evaluate treatment outcomes.
Other Names:
Testing involves trainer-guided practice of computerbased video "games."
The "games" require the "player" to identify targets that are presented very briefly.
In the first level, the player has to identify a target at the center of the screen.
In the second level, the player has to identify targets at the center and edge of the screen simultaneously.
In the third level, other objects, which serve as decoys, are added.
SOPT is aimed at improving the fluidity of mental processing speed (not psychomotor reaction time) so that trainees can process more complex information over briefer periods of time.
The training involves practice with feedback.
The trainer teaches some task-specific strategies, offer suggestions, encouragement, and personalized modification of difficulty for enhancing performance.
Speed and task difficulty level are tailored to trainee ability, trainees practice blocks of 16 trials with a goal of achieving performance of 10 to 12 correct trials for each training block.
Other Names:
In addition to training on the SOPT software, participants will train on tasks that simulate everyday activities that have important cognitive components (e.g., selecting medicine bottles from a cabinet, measuring ingredients to bake a cake, finding information online).
The training will follow shaping principles.
Activity periods will be divided into trials of specific length, and the performance of the participant will be measured and graphed to provide the participant with feedback on their performance.
Verbal praise will be used to reward a participant for improvements in performance.
The difficulty of the task will be increased in small increments as a participant gains mastery.
The purpose of this component is to serve as a bridge between the SOPT training, which exercises a basic aspect of cognitiven function, and cognitive function in everyday life, which is embedded in the context of multi-part, and multidimensional tasks.
Other Names:
|
Other: Delayed Treatment
Participants in this arm will receive testing on the same schedule as the Immediate Treatment up to six-month followup.
Delayed Treatment participants will not receive any treatment from the study during this period but will permitted to receive any healthcare that is available on a clinical basis.
After six-month followup, participants in this arm will be crossed over to receive the experimental treatment.
|
Behavioral Contract.
At the outset of treatment, the therapist negotiates a contract with the participant and caregiver, if one is available.Daily home diary.
During treatment, the participants catalog the ADL and IADL for the part of the day spent outside the laboratory.
Daily administration of the Cognitive Task Activity Log (CTAL).
The CTAL collects information about attempts by the participant to complete ADL and IADL.
Problem Solving.
The therapist helps participants to think through any barriers to completing ADL and IADL independently.
Home skill assignments during treatment.
Participants are assigned on a written check-off sheet 10 specific ADL tasks.
Home skill assignments after treatment.
Toward the end of treatment, a written individualized post-treatment program is developed containing a list of up to 10 IADL for each day of the week.
Post-treatment telephone contacts.
Participants are contacted during the 12 month period after treatment to evaluate treatment outcomes.
Other Names:
Testing involves trainer-guided practice of computerbased video "games."
The "games" require the "player" to identify targets that are presented very briefly.
In the first level, the player has to identify a target at the center of the screen.
In the second level, the player has to identify targets at the center and edge of the screen simultaneously.
In the third level, other objects, which serve as decoys, are added.
SOPT is aimed at improving the fluidity of mental processing speed (not psychomotor reaction time) so that trainees can process more complex information over briefer periods of time.
The training involves practice with feedback.
The trainer teaches some task-specific strategies, offer suggestions, encouragement, and personalized modification of difficulty for enhancing performance.
Speed and task difficulty level are tailored to trainee ability, trainees practice blocks of 16 trials with a goal of achieving performance of 10 to 12 correct trials for each training block.
Other Names:
In addition to training on the SOPT software, participants will train on tasks that simulate everyday activities that have important cognitive components (e.g., selecting medicine bottles from a cabinet, measuring ingredients to bake a cake, finding information online).
The training will follow shaping principles.
Activity periods will be divided into trials of specific length, and the performance of the participant will be measured and graphed to provide the participant with feedback on their performance.
Verbal praise will be used to reward a participant for improvements in performance.
The difficulty of the task will be increased in small increments as a participant gains mastery.
The purpose of this component is to serve as a bridge between the SOPT training, which exercises a basic aspect of cognitiven function, and cognitive function in everyday life, which is embedded in the context of multi-part, and multidimensional tasks.
Other Names:
Healthcare that is available for adults with cognitive impairment subsequent to COVID-19 in the community on a clinical basis.
This includes commercially available, gamified, computerized cognitive training programs.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Canadian Occupation Performance Measure (COPM)
Time Frame: Change from Day 0 to Day 17
|
The COPM is a widely used, transdiagnostic, individualized, structured interview that detects changes over time in a respondent's performance of five, self-selected activities of daily living (ADL).
In this case, the instrument will be completed by a family caregiver and only assess instrumental ADL (IADL) with important cognitive components.
Performance is rated using 10-point scale that ranges from 1-10 scale points.
High scores reflect effective performance.
The test score is the mean of the ratings of the five, self-selected IADL.
|
Change from Day 0 to Day 17
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improved and New Cognitive Ability (INCA)
Time Frame: Change from Day 0 to Day 17
|
The INCA gathers a comprehensive record of participant changes in everyday Instrumental Activities of Daily Living (IADL) with important cognitive components that have been observed since the start of training.
These can be reported by the participant (when possible), the caregiver, or other friends and family that have spent time with the participant.
The test score is a count; it is the number of new and improved activities with important cognitive components that a participant has been observed to undertake in their daily life since beginning training.
The range is 0 to infinite.
|
Change from Day 0 to Day 17
|
Cognitive Task Activity Log (CTAL) How Well Scale
Time Frame: Change from Day 0 to Day 17
|
The CTAL quantifies how well and independently participants complete activities of daily living (ADL) and instrumental ADL (IADL) outside the treatment setting.
Twenty-two activities with important cognitive components are surveyed; each is rated by the family caregiver using 11-point scales.
The How Well Scale is reported here.
The range is 0-5 scale points; high scores reflect effective performance of the activities.
|
Change from Day 0 to Day 17
|
Cognitive Task Activity Log (CTAL) Independence Scale
Time Frame: Change from Day 0 to Day 17
|
The CTAL quantifies how well and independently participants complete activities of daily living (ADL) and instrumental ADL (IADL) outside the treatment setting.
Twenty-two activities with important cognitive components are surveyed; each is rated by the family caregiver using 11 point scales.
The Independence Scale is reported.
The range is 0-5 scale points; high scores reflect performance of the activities without assistance from others.
|
Change from Day 0 to Day 17
|
Assessment of Motor and Process Skills (AMPS)
Time Frame: Change from Day 0 to Day 17
|
The Assessment of Motor & Process Skills is a widely used, transdiagonistic performance test.
Patients will be asked to perform four typical IADL with important cognitive components in the lab.
The tasks will be selected from a bank of 125 standardized, Rasch-calibrated tasks.
Two sets of four tasks of similar difficulty and type will be assembled and presented in counterbalanced order to reduce the influence of any practice or other order effects.
Performance will be videotaped and scored by independent raters masked to group assignment and testing order.
The Process Scale score only will be calculated.
Scores range from -5 to 5 logits.
High scores reflect effective performance of the tasks.
|
Change from Day 0 to Day 17
|
Collaborators and Investigators
Investigators
- Principal Investigator: Edward Taub, University of Alabama at Birmingham
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300002814C
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid-19
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
Massachusetts General HospitalRecruitingPost Acute COVID-19 Syndrome | Long COVID | Post Acute Sequelae of COVID-19 | Long COVID-19United States
-
Indonesia UniversityRecruitingPost-COVID-19 Syndrome | Long COVID | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19Indonesia
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNot yet recruitingPost-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post-COVID ConditionNetherlands
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecruitingCOVID-19 Pandemic | COVID-19 Vaccines | COVID-19 Virus DiseaseIndonesia
-
University of Witten/HerdeckeInstitut für Rehabilitationsforschung NorderneyCompletedPost-COVID-19 Syndrome | Long-COVID-19 SyndromeGermany
-
Jonathann Kuo, MDActive, not recruitingSARS-CoV2 Infection | Post-COVID-19 Syndrome | Dysautonomia | Post Acute COVID-19 Syndrome | Long COVID | Long Covid19 | COVID-19 Recurrent | Post-Acute COVID-19 | Post-Acute COVID-19 Infection | Post Acute Sequelae of COVID-19 | Dysautonomia Like Disorder | Dysautonomia Orthostatic Hypotension Syndrome | Post... and other conditionsUnited States
-
University Hospital, Ioannina1st Division of Internal Medicine, University Hospital of IoanninaRecruitingCOVID-19 Pneumonia | COVID-19 Respiratory Infection | COVID-19 Pandemic | COVID-19 Acute Respiratory Distress Syndrome | COVID-19-Associated Pneumonia | COVID 19 Associated Coagulopathy | COVID-19 (Coronavirus Disease 2019) | COVID-19-Associated ThromboembolismGreece
Clinical Trials on Transfer Package from CI Therapy
-
University of Alabama at BirminghamRecruiting
-
University of Alabama at BirminghamUnited States Department of DefenseCompletedTraumatic Brain InjuryUnited States
-
University of Alabama at BirminghamCompletedStroke | Gait, Hemiplegic | Behavior and Behavior MechanismsUnited States
-
Ohio State UniversityUniversity of Missouri-Columbia; University of Alabama at Birmingham; University... and other collaboratorsCompletedEffectiveness of Virtual Reality Gaming Therapy Versus CI Therapy for Upper Extremity RehabilitationStroke | HemiparesisUnited States
-
Ohio State UniversityActive, not recruitingStroke | HemiparesisUnited States
-
University of Massachusetts, LowellOhio State UniversityCompletedHemiparesis | Primary Progressive Multiple SclerosisUnited States
-
National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Imperial College LondonWellcome Trust; World Bank; Biomedical Research and Training Institute; UNICEF; Catholic...CompletedEducation | Vaccination | Birth Registration | Financial SupportZimbabwe
-
University of Alabama at BirminghamEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedStrokeUnited States
-
Natural Immune Systems IncRecruitingImmune SurveillanceUnited States